Zatelli, Maria Chiara <br/><br/>
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids.  [electronic resource] 

 -  Endocrine-related cancer  Sep 2010 
 - 719-29 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1479-6821 
<br/><br/><label>Standard No.: </label>10.1677/ERC-10-0097  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Blotting, Western<br/>Bronchial Neoplasms--drug therapy<br/>Carcinoid Tumor--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Everolimus<br/>Female<br/>Humans<br/>Immunoenzyme Techniques<br/>Immunosuppressive Agents--pharmacology<br/>Intracellular Signaling Peptides and Proteins--genetics<br/>Male<br/>Middle Aged<br/>Protein Serine-Threonine Kinases--genetics<br/>Proto-Oncogene Proteins c-akt--genetics<br/>RNA, Messenger--genetics<br/>Receptors, Somatostatin--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Ribosomal Protein S6 Kinases, 70-kDa--genetics<br/>Signal Transduction<br/>Sirolimus--analogs & derivatives<br/>TOR Serine-Threonine Kinases<br/>Vascular Endothelial Growth Factor A--genetics